Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
about
Translocation of PEGylated quantum dots across rat alveolar epithelial cell monolayersMonocytes and macrophages as nanomedicinal targets for improved diagnosis and treatment of disease.Macrophage targeted theranostics as personalized nanomedicine strategies for inflammatory diseases.Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivoHalothane modulates the type i interferon response to influenza and minimizes the risk of secondary bacterial pneumonia through maintenance of neutrophil recruitment in an animal model.Pre-clinical optical molecular imaging in the lung: technological challenges and future prospectsQuantum dots for cancer research: current status, remaining issues, and future perspectives.Quantum dot-based nanoprobes for in vivo targeted imaging.Photosensitive fluorescent dye contributes to phototoxicity and inflammatory responses of dye-doped silica NPs in cells and mice.Preparation of quantum dot/drug nanoparticle formulations for traceable targeted delivery and therapyMechanisms of absorption and elimination of drugs administered by inhalation.Controlling the actuation of therapeutic nanomaterials: enabling nanoparticle-mediated drug delivery.Quantum dots: bright and versatile in vitro and in vivo fluorescence imaging biosensors.Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages.Pharmaceutical and biomedical applications of quantum dots.Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery.In one harness: the interplay of cellular responses and subsequent cell fate after quantum dot uptake.In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer.Metalloestrogenic effects of quantum dots.Meta-analysis of cellular toxicity for cadmium-containing quantum dots.Targeted anticancer drug delivery through anthracycline antibiotic bearing functionalized quantum dots.Fluorescence Determination of Warfarin Using TGA-capped CdTe Quantum Dots in Human Plasma Samples.Utility and Potential Application of Nanomaterials in MedicineFunctional Nanomaterials for Multifarious NanomedicineFluorescence Blinking as an Output Signal for BiosensingPredictable Irreversible Switching Between Acute and Chronic InflammationExpression and significance of quantum dots in RAW 264.7 macrophages
P2860
Q28394182-C00866E0-6056-4B3B-A80A-45FA52A8E2E7Q33949943-CA3250D4-5BE0-44F2-A209-5BEA6B601157Q34785236-E7E99B5A-7576-4079-8619-D12DAF97B1F7Q35833755-92DBA6B6-B693-4118-8044-9DD6EB892910Q36369118-690387EF-31D0-44AE-BD0C-F2DBF877D52AQ36424421-DCF3C8A3-B160-4B7E-83CA-70930E628682Q36814396-4414B719-834F-44D9-A366-EAFF6E199DF8Q37337213-D1974066-C4A5-40F9-BC9F-C81964340207Q37605956-5EA514E6-2A94-4B80-869F-B9AC94ED97D8Q38034961-2F9EF320-9F51-49A6-8EFD-200BC8024CD1Q38126941-2E6E50B2-5C4C-43D0-9CD3-5B53A3D1A576Q38162492-28A15D50-2AE1-4B67-87AB-3CD1004B4794Q38380533-6B0C35FD-C4BE-450E-BB5D-675127FE669BQ38442447-28F6D1B5-F8F3-4F19-BF5B-1AB846EB4780Q38522304-8A39E5CD-3757-4333-81AB-BB020EFB6823Q38939434-76745608-C8BC-49A3-A67C-DC766512A81CQ38952176-87219F78-122C-4990-88F0-381260DACFA9Q39296686-5B29E313-0C9D-4329-9159-5887A5972A86Q39455954-4946AEDB-FCB6-4EED-B941-52ADC8661536Q39960471-BB2146A3-F9FD-488E-8D87-99397A646EAFQ51669932-3F453C51-6C95-4C6D-8C3E-F0C985CDBEF8Q51681636-21F534FF-9317-4A2B-95E9-9332CB23462CQ57340460-53CF20F8-E733-402C-A7BD-6B7ED28AA207Q57340480-7C14A953-552E-433A-9B45-68F229073888Q57429825-B9DD343E-7574-4B98-8731-28A30E397B6AQ58034049-0C7C6110-9602-40FB-90A9-53472D8B2130Q58573368-408C8A2B-AC38-4532-8492-8418B522A354
P2860
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
@ast
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
@en
type
label
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
@ast
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
@en
prefLabel
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
@ast
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
@en
P2093
P2860
P1476
Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation.
@en
P2093
Bruce A Davidson
Jadwiga D Helinski
Ken-Tye Yong
Krishnan V Chakravarthy
Paras N Prasad
Paul R Knight
P2860
P356
10.1016/J.NANO.2010.09.001
P577
2010-09-29T00:00:00Z